↑ Grab this Headline Animator

Whos Developing What in New Cancer Drugs 2005

Research and Markets (http://www.researchandmarkets.com/reports/c24674) has announced the addition of Who's Developing What in New Cancer Drugs 2005 to their offering



Over 1,200-pages analysing the structure, performance and research of over 135 leading cancer drug development companies.



Cancer continues to dominate industry research and investment as the search for really effective therapies hots up. The commercial rewards for companies that make significant breakthroughs in the cure or control of key cancers such as breast, ovarian, lung and prostate are considerable.



The application of biotechnology to the identification and development of drug candidates has seen a range of novel paths pursued by a number of development companies.



For analysts, investors and pharmaceutical company executives, being able to readily and easily assess these companies, the research they are pursuing, products being developed, collaborators and financial performance/funding is key to understanding this sector of the market.



That is why the new 4th edition of this respected management report, Who's Developing What in New Cancer Drugs 2005 is the essential reference work for everyone in the field. The report covers more than 135 companies - from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.



For more information visit http://www.researchandmarkets.com/reports/c24674



Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Webcom | Websource Cpq | low voltage products |

---

4870 readers online...

, Local News